Valuation — not yet established
No valuation for Jumpcode Genomics is on record yet — no priced round, mark, or trade has surfaced in our sources. Total raised ($44.2M) and the funding record below are the closest available signals.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
See the evidence behind this price
- ·Post-money valuations for all 5 rounds
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Jumpcode Genomics
Create free account
No card required
Funding history
5 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Aug 2024 | Seed Round | $3.5M | ▮ | ▮ |
| Apr 2023 | Early Stage VC | $9.2M | ▮ | ▮ |
| Dec 2020 | Early Stage VC | $21.0M | ▮ | ▮ |
| Jan 2020 | Seed Round | $1.5M | ▮ | ▮ |
| Sep 2018 | Seed Round | $3.5M | ▮ | ▮ |
How Jumpcode Genomics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Jumpcode Genomics, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- How much has Jumpcode Genomics raised?
- Jumpcode Genomics has raised $44.2M in total funding across 5 recorded rounds.
- When did Jumpcode Genomics last raise?
- Jumpcode Genomics last raised in Aug 2024 (Seed Round), raising $3.5M.